About-cancer/treatment/drugs/lenalidomide

From loveco.care
Revision as of 10:45, 25 October 2019 by Danna (talk | contribs) (Created page with "== Lenalidomide == This page contains brief information about lenalidomide and a collection of links to more information about the use of this drug, research results, and on...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Lenalidomide

This page contains brief information about lenalidomide and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Revlimid

FDA Approved

Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Lenalidomide is approved to treat:

  • Anemia caused by certain types of myelodysplastic syndromes. It is used in adults.
  • Follicular lymphoma in adults who have already received other treatment.
  • Mantle cell lymphoma in adults whose disease recurred (came back) or got worse after two other treatments,including bortezomib.
  • Marginal zone lymphoma in adults who have already received other treatment. It is used with rituximab.
  • Multiple myeloma in adults. It is given with dexamethasone. It is also used alone as maintenance therapy in adults *who received an autologous stem cell transplant.

Lenalidomide is only available as part of a special program called Revlimid REMS (Risk Evaluation and Mitigation StrategiesExit Disclaimer).

Lenalidomide is also being studied in the treatment of other conditions and types of cancer.

More About Lenalidomide

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Lenalidomide - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Drug Shows Promise in Slowing Progression of Smoldering Myeloma to Cancer

FDA Approves New Use for Lenalidomide in Multiple Myeloma

Three-Drug Combination Extends Survival for Patients with Multiple Myeloma

Three-Drug Combination Benefits Some Patients With Relapsed Multiple Myeloma

Clinical Trials Accepting Patients

Find Clinical Trials for Lenalidomide - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.

Retrieved from "http://www.loveco.care/index.php?title=About-cancer/treatment/drugs/lenalidomide&oldid=1251"